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A B S T R A C T
 
Aspergillosis of the central nervous system (CNS) is an uncommon infection, mainly found in 
immunocompromised patients but rarely seen among immunocompetent patients. Herein 
we describe a 57 year-old immunocompetent man who suffered intracranial aspergillosis 
spread by the pterygopalatine fossa (PPF) following a tooth extraction. Based on magnetic 
resonance imaging (MRI) characteristics, in this report we focus on the spreading routes 
of CNS aspergillosis via communicative structures of the PPF, the relationship between 
clinical manifestations and the locations of the lesion, and propose a therapeutic strategy 
to improve the prognosis.
Case presentation
A 57-year-old male had suffered from persistent head-
ache for 20 months on the left occipitotemporal side 
after a tooth extraction, followed by a decrease of his 
left visual acuity and disordered speech. On neurologi-
cal examinations, his left eye fixed with light reflex dis-
appeared, the ipsilateral palpebral fissure became nar-
row in response to his eyelid weakness, and the tem-
poralis and masseter muscles were weak with apparent 
atrophy. Moreover, his left side hearing declined, his left 
face felt numb, and his memory deteriorated. On mag- 
netic resonance imaging (MRI) of the head, an enlarged 
mass with hypo-intense signal on T2WI and T1WI in the 
left pterygopalatine fossa (PPF) was shown, involving 
the ipsilateral sphenoid sinus, cavernous sinus, inferior 
orbital fissure, and temporal and frontal lobes. The left 
pterygopalatine canal was obviously enlarged with abnor-
mal signal intensity. The contrast enhanced T1WI showed 
strong enhancement at the aforementioned regions (Fig. 
1). In order to confirm the nature of the mass, a trans-
nasal biopsy of the PPF was carried out. The histological 
result revealed the rare finding of Aspergillus. Antifungal 
therapy was immediately started with vorionazole and 
amphotericin B. However, his condition was not satisfac-
torily under control after a long period of antibiotic therapy. 
A surgical operation was then arranged, and preoperation 
examinations were completed. The patient underwent 
a left pterion craniotomy with resection of skull base 
occupying lesions. The multiple intradural lesions were 
excised, and Aspergillus was proved again by intraoperative 
biopsy. The lesion had a light yellowish color and a hard 
consistency that was tightly adhered to the nearby tissue, 
especially to the left middle cerebral artery. After incision, the 
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Fig. 1 - Preoperative MRI of CNS aspergillosis. On the post-
gadolinium T1WI, the destroyed and enlarged left vidan 
canal (A, white arrowhead), foramen rotundum (B, black 
arrow), as well as the oval foramen (D, black arrow) were 
enhanced compared with the right ones. Simultaneously, 
the left PPF (A, B, white arrow), orbital apex (C, white 
arrowhead), and foramen lacerum (A, B, black arrow) 
with heterogeneous enhancement and the ipsilateral 
cavernous sinus (C, D, white arrow) and temporal lobe 
(C, black arrow) with multiple circle enhancements were 
shown, moreover the left internal carotid artery (C, black 
arrowhead) surrounded by the lesions was also displayed. 
The enlarged left pterygopalatine canal (E, white arrow), 
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sticky milky pus was drained. The bone and the dura of 
the left skull base were partly eroded by Aspergillus. 
Unfortunately, the postoperative MRI (Fig. 2), performed 
33 days after surgery, showed further deterioration of the 
lesion, which enlarged in the anterior left orbit and destroyed 
the Meckel’s cave, entering the Cerebellopontine angle (CPA) 
and involving the posterior root of trigeminal nerve. As the 
disease progressed, his condition gradually worsened to 
a coma, and finally he died on the 42nd day after surgery.
Discussion
Aspergillosis is a common opportunistic infection 
in  immunocompromised hosts  but  quite  rare  in 
immunocompetent patients. Intracranial aspergillosis 
accounts for 5% of all the CNS fungal infections.1 The overall 
prognosis of craniocerebral aspergillosis is poor. Mortality is 
reported to reach 100% in immunocompromised and 67% in 
immunocompetent hosts.2 The lungs and maxillary sinusitis 
are the most common sites of primary aspergillosis.3-5 
Intracranial spread of Aspergillus infection occurs more 
Fig. 2 - Postoperative MRI of CNS aspergillosis on the 33rd 
day. On the post-gadolinium T1WI, a vast lesion occupying 
the left orbital apex and orbit was strongly enhanced. The 
enhanced focus located at the left cerebellopontine angle 
(CPA) (black arrow) involving the root of trigeminal nerve 
(black arrowhead) was clearly shown.
frequently by haematogenous routes, and less frequently 
through direct or contiguous spread.2-4 Contiguous spread can 
always be seen in the PPF, which communicates intracranially 
via channels. As its extent and location are different, clinical 
manifestations are subtle, frequently presenting features 
of meningitis, meningoencephalitis, focal neurological signs, or 
symptoms of raised intracranial pressure.
The PPF is an important anatomic site that communicates 
with the oral cavity via pterygopalatine canal, nasal cavity via 
sphenopalatine foramen, orbit via inferior orbital fissure, and 
middle cranial fossa via foramen rotundum. Infectious 
and tumor lesions in these regions can disseminate through 
the PPF, and meanwhile the related channels are always found 
enlarged or destroyed in the radiologic and pathologic exams. 
Due to the tooth extraction followed by constant headache 
and abnormal signals at the pterygopalatine canal on MRI, we 
propose that Aspergillus invaded the pterygopalatine canal, 
ascending via the greater and lesser palatine canals, and finally 
reached the PPF in our patient. 
Concerning the probable route of this infection, which 
extended intracranially and perineurally based on the image 
evidence, we consider that the PPF was a crucial site. The left 
PPF and foramen rotundum were enlarged, and simultaneously 
the damaged connected structures, as the inferior orbital 
fissure and the vidian canal, were clearly shown on MRI. 
The foramen rotundum is a significant access to the middle 
cranial fossa from the PPF. The lesions, spreading through 
the foramen rotundum, frequently invade cavernous sinuses, 
temporal lobes, and the dura, resulting in the related clinical 
presentations. The symptoms and signs of our patient, 
including left facial numbness, decrease of left visual acuity, 
disappearance of ipsilateral eye fixation with light reflex, 
and eyelid weakness, corresponded to the involvement 
of the aforementioned regions. The inferior orbital fissure, 
the antero-superior cleft of the PPF, runs inferior orbital 
nerve through which infectious lesion from PPF may invade 
the orbit. In the present case, the damage to the left inferior 
orbital fissure and a mass in the orbit were demonstrated on 
the imaging, indicating that the orbital focus originated the 
PPF. Also, the lesions of PPF subsequently infected the foramen 
lacerum via the vidian nerve and were enhanced on the contrast-
enhanced T1WI, and the lesion on the foramen lacerum might 
superiorly involve the posterior part of cavernous sinuses. The 
PPF communicates with the infratemporal fossa, which contains 
masticatory muscles and is located underneath the skull base 
of the middle cranial fossa, via the pterygomandibular fissure. 
Lesions of either the middle cranial fossa or the infratemporal 
fossa may communicate with each other by destroying the skull 
base. In the current case, his left masticatory muscles, dominated 
by the third division of the trigeminal nerve, which passes 
through the oval foramen, became atrophied. And the images 
proved the apparent damage on the skull base of the middle 
cranial fossa, consistent with its clinical manifestations. On the 
other hand, abnormal enhanced lesions located at the left CPA 
and at the trigeminal nerve root were shown on the enhanced-
T1WI. Probable causes of the involvement of the posterior cranial 
fossa might be either the spread from the middle cranial fossa 
by crossing the petrous apex and Meckel’s cave posteriorly, or 
invasion through the petro-occipital suture superiorly. 
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Consistent with the literature,2 intracranial aspergillosis’ 
typical MRI features appear as hypo-intense signals 
on T1-weighted and T2-weighted images, and as heterogeneous 
and multiple peripheral enhancements on post-gadolinium 
T1-weighted images. 
The conventional treatment for invasive aspergillosis 
used to be amphotericin B. However, amphotericin B alone 
showed few encouraging results, especially in refractory fungal 
infections.5 Voriconazole has proven to be significantly superior 
to conventional amphotericin B, and has led to a profound 
survival improvement in patients with CNS aspergillosis.2,6 
Combination therapies with two antifungal compounds are the 
common treatment protocol. Although the surgical treatment 
of Aspergillus infection is still controversial, our experience is 
that surgery combined with antifungal therapy may improve 
survival.
The prognosis of aspergillosis is closely related with the 
location and the extension of the lesion. Once the PPF has 
been involved, the infectious lesion would be very intractable. 
Although the vast majority of his intracranial lesions were 
resected during the operation, the focus of the pterygopalatine 
fossa and the orbit still remained. In our opinion, his poor 
prognosis was attributed to his elder age, longtime course, 
and the widespread infection caused by the rapid progression 
in size and number of lesions. Based on the literature,7-9 
we propose that diagnosing the disease based on radiologic 
or pathologic findings in the early stage, starting combined 
antifungal therapies, and even performing surgical treatment 
if necessary could possibly improve the prognosis of patients 
with CNS aspergillosis.
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